aldosterone has been researched along with Overweight in 14 studies
Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Decreases in aldosterone were associated with decreases in C-reactive protein, leptin, insulin, homeostasis assessment of insulin resistance, heart rate, tonic cardiac sympathovagal balance and increases in adiponectin (all P<0." | 9.17 | Changes in serum aldosterone are associated with changes in obesity-related factors in normotensive overweight and obese young adults. ( Barinas-Mitchell, E; Conroy, MB; Cooper, JN; Evans, RW; Fried, L; Mori Brooks, M; Sutton-Tyrrell, K; Tepper, P; Woodard, GA, 2013) |
| "Insulin resistance was estimated by the homeostasis model assessment." | 5.35 | Aldosterone contributes to blood pressure variance and to likelihood of hypertension in normal-weight and overweight African Americans. ( Grim, CE; Kidambi, S; Kotchen, JM; Kotchen, TA; Krishnaswami, S, 2009) |
| " Decreases in aldosterone were associated with decreases in C-reactive protein, leptin, insulin, homeostasis assessment of insulin resistance, heart rate, tonic cardiac sympathovagal balance and increases in adiponectin (all P<0." | 5.17 | Changes in serum aldosterone are associated with changes in obesity-related factors in normotensive overweight and obese young adults. ( Barinas-Mitchell, E; Conroy, MB; Cooper, JN; Evans, RW; Fried, L; Mori Brooks, M; Sutton-Tyrrell, K; Tepper, P; Woodard, GA, 2013) |
| "The aim of this study was to assess novel inflammatory markers [adipokines leptin, adiponectin, and leptinadiponectin ratio (L/A)] in overweight women with and without PCOS and to examine alterations in these markers [aldosterone, leptin, adiponectin, and L/A] with pharmacological interventions modulating insulin resistance (IR) in PCOS." | 5.14 | Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention. ( Hutchison, SK; Meyer, C; Moran, LJ; Teede, HJ; Zoungas, S, 2010) |
| " The reasons for low MSNA and a lack of sympathetically mediated support of REE after gastric bypass are likely multifactorial and may be related to changes in insulin sensitivity, body composition, and leptin, among other factors." | 3.79 | Sympathetic support of energy expenditure and sympathetic nervous system activity after gastric bypass surgery. ( Charkoudian, N; Curry, TB; Groenewald, CB; Hines, CN; Joyner, MJ; Miles, JM; Somaraju, M, 2013) |
| "Obesity has been recognized as an independent risk factor for arterial hypertension." | 1.37 | Arterial hypertension in obesity: relationships with hormone and anthropometric parameters. ( De Pergola, G; Guida, P; Nardecchia, A; Silvestris, F, 2011) |
| "Insulin resistance was estimated by the homeostasis model assessment." | 1.35 | Aldosterone contributes to blood pressure variance and to likelihood of hypertension in normal-weight and overweight African Americans. ( Grim, CE; Kidambi, S; Kotchen, JM; Kotchen, TA; Krishnaswami, S, 2009) |
| "Primary hyperaldosteronism (PH), resulting in hypokalaemic hypertension, may be due to an aldosterone-producing adenoma (APA) or bilateral zona glomerulosa hyperplasia." | 1.34 | Prospective evaluation and characteristics of patients with suspected primary hyperaldosteronism. ( Boyne, MS; McKenzie, CA; Wright-Pascoe, R, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curry, TB | 1 |
| Somaraju, M | 1 |
| Hines, CN | 1 |
| Groenewald, CB | 1 |
| Miles, JM | 1 |
| Joyner, MJ | 1 |
| Charkoudian, N | 1 |
| Cooper, JN | 2 |
| Fried, L | 1 |
| Tepper, P | 2 |
| Barinas-Mitchell, E | 2 |
| Conroy, MB | 1 |
| Evans, RW | 1 |
| Mori Brooks, M | 1 |
| Woodard, GA | 2 |
| Sutton-Tyrrell, K | 2 |
| Rossi, GP | 2 |
| Seccia, TM | 1 |
| De Pergola, G | 2 |
| Campobasso, N | 1 |
| Nardecchia, A | 2 |
| Triggiani, V | 1 |
| Caccavo, D | 1 |
| Gesualdo, L | 1 |
| Silvestris, F | 2 |
| Manno, C | 1 |
| Kidambi, S | 1 |
| Kotchen, JM | 1 |
| Krishnaswami, S | 1 |
| Grim, CE | 1 |
| Kotchen, TA | 1 |
| Moran, LJ | 1 |
| Meyer, C | 1 |
| Hutchison, SK | 1 |
| Zoungas, S | 1 |
| Teede, HJ | 1 |
| Fogari, R | 1 |
| Zoppi, A | 1 |
| Corradi, L | 1 |
| Preti, P | 1 |
| Mugellini, A | 1 |
| Lazzari, P | 1 |
| Derosa, G | 1 |
| Guida, P | 1 |
| Vleugels, K | 1 |
| Schinner, S | 1 |
| Krause, D | 1 |
| Morawietz, H | 1 |
| Bornstein, SR | 1 |
| Ehrhart-Bornstein, M | 1 |
| Krug, AW | 1 |
| Bender, SB | 1 |
| McGraw, AP | 1 |
| Jaffe, IZ | 1 |
| Sowers, JR | 1 |
| Bentley-Lewis, R | 1 |
| Adler, GK | 1 |
| Perlstein, T | 1 |
| Seely, EW | 1 |
| Hopkins, PN | 1 |
| Williams, GH | 1 |
| Garg, R | 1 |
| McKenzie, CA | 1 |
| Wright-Pascoe, R | 1 |
| Boyne, MS | 1 |
| Belfiore, A | 1 |
| Bernini, G | 1 |
| Fabris, B | 1 |
| Caridi, G | 1 |
| Ferri, C | 1 |
| Giacchetti, G | 1 |
| Letizia, C | 1 |
| Maccario, M | 1 |
| Mannelli, M | 1 |
| Palumbo, G | 1 |
| Patalano, A | 1 |
| Rizzoni, D | 1 |
| Rossi, E | 1 |
| Pessina, AC | 1 |
| Mantero, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Trial to Reverse Early Arterial Stiffening[NCT00366990] | 349 participants (Actual) | Interventional | 2007-01-31 | Completed | |||
| Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension[NCT05593055] | Phase 4 | 75 participants (Anticipated) | Interventional | 2023-08-25 | Recruiting | ||
| Oral Potassium Supplementation in Healthy Men - Interactions With the Renin-angiotensin-aldosterone System and the Sympathetic Nervous System[NCT02380157] | Phase 4 | 25 participants (Actual) | Interventional | 2015-03-31 | Completed | ||
| Salt Sensitive Hypertension and Striatin[NCT03683069] | Phase 4 | 400 participants (Actual) | Interventional | 2019-01-15 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for aldosterone and Overweight
| Article | Year |
|---|---|
Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?
Topics: Aldosterone; Animals; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Human | 2013 |
4 trials available for aldosterone and Overweight
| Article | Year |
|---|---|
Changes in serum aldosterone are associated with changes in obesity-related factors in normotensive overweight and obese young adults.
Topics: Adiponectin; Adiposity; Adult; Aldosterone; Blood Pressure; C-Reactive Protein; Diet, Sodium-Restric | 2013 |
Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.
Topics: Adiponectin; Adiposity; Aldosterone; Biomarkers; Body Mass Index; Cross-Sectional Studies; Female; H | 2010 |
Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension.
Topics: Aged; Aldosterone; Blood Glucose; Blood Pressure; Body Mass Index; Diet, Reducing; Female; Humans; H | 2010 |
Serum aldosterone is associated with inflammation and aortic stiffness in normotensive overweight and obese young adults.
Topics: Adult; Aldosterone; Ankle Brachial Index; Biomarkers; Blood Pressure; Cross-Sectional Studies; Exerc | 2012 |
9 other studies available for aldosterone and Overweight
| Article | Year |
|---|---|
Sympathetic support of energy expenditure and sympathetic nervous system activity after gastric bypass surgery.
Topics: Adolescent; Adult; Aldosterone; Basal Metabolism; Blood Glucose; Body Composition; Body Mass Index; | 2013 |
Changes in aldosterone and obesity-related cardiometabolic risk factors with a 1-year weight loss intervention in normotensive overweight and obese young adults.
Topics: Aldosterone; Female; Humans; Male; Obesity; Overweight | 2013 |
Para- and perirenal ultrasonographic fat thickness is associated with 24-hours mean diastolic blood pressure levels in overweight and obese subjects.
Topics: Adipose Tissue; Adult; Aldosterone; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambula | 2015 |
Aldosterone contributes to blood pressure variance and to likelihood of hypertension in normal-weight and overweight African Americans.
Topics: Adult; Aldosterone; Black or African American; Blood Pressure; Body Mass Index; Cross-Sectional Stud | 2009 |
Arterial hypertension in obesity: relationships with hormone and anthropometric parameters.
Topics: Adult; Aldosterone; Biomarkers; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory | 2011 |
ERK1/2 MAPKs and Wnt signaling pathways are independently involved in adipocytokine-mediated aldosterone secretion.
Topics: Adipocytes; Adipokines; Adrenal Cortex; Aldosterone; beta Catenin; Cell Communication; Cell Line; Ce | 2011 |
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
Topics: Adult; Aldosterone; Angiotensin II; Body Mass Index; Diet; Female; Humans; Hydrocortisone; Infusions | 2007 |
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
Topics: Adult; Aldosterone; Angiotensin II; Body Mass Index; Diet; Female; Humans; Hydrocortisone; Infusions | 2007 |
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
Topics: Adult; Aldosterone; Angiotensin II; Body Mass Index; Diet; Female; Humans; Hydrocortisone; Infusions | 2007 |
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
Topics: Adult; Aldosterone; Angiotensin II; Body Mass Index; Diet; Female; Humans; Hydrocortisone; Infusions | 2007 |
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
Topics: Adult; Aldosterone; Angiotensin II; Body Mass Index; Diet; Female; Humans; Hydrocortisone; Infusions | 2007 |
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
Topics: Adult; Aldosterone; Angiotensin II; Body Mass Index; Diet; Female; Humans; Hydrocortisone; Infusions | 2007 |
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
Topics: Adult; Aldosterone; Angiotensin II; Body Mass Index; Diet; Female; Humans; Hydrocortisone; Infusions | 2007 |
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
Topics: Adult; Aldosterone; Angiotensin II; Body Mass Index; Diet; Female; Humans; Hydrocortisone; Infusions | 2007 |
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
Topics: Adult; Aldosterone; Angiotensin II; Body Mass Index; Diet; Female; Humans; Hydrocortisone; Infusions | 2007 |
Prospective evaluation and characteristics of patients with suspected primary hyperaldosteronism.
Topics: Adult; Aldosterone; Body Mass Index; Female; Glucose Intolerance; Humans; Hyperaldosteronism; Hypert | 2007 |
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients.
Topics: Aldosterone; Body Mass Index; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Overweight; | 2008 |